Company intelligence / Profile preview
NeoMatrix Therapeutics
Stony Brook, New York, United Statesneomatrixtx.com ↗
- Ownership
- Private
- Development stage
- Phase 2
01
Overview
NeoMatrix Therapeutics develops novel bioactive peptides that prevent the progression of tissue injury after severe burns. Their lead candidate, NMT-cP12, has entered a Phase 2a clinical trial with promising results in reducing healing time and scarring. The second candidate, NMT-cNP8, has completed Phase 1 trials and shows antimicrobial properties suitable for topical application. Both candidates have demonstrated efficacy in preclinical models and early human studies.[1][2]
- Therapeutic areas
- OtherDermatology
- Modalities
- Bioactive peptides (notably NMT-cP12 and NMT-cNP8)[1][2][5]
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →03
Partnerships
U.S. Army Medical Research funding since at least 2012 for both lead programs; no major pharma partnerships disclosed.[2]
Beyond the preview
Go deeper on NeoMatrix Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on NeoMatrix Therapeutics.